Anest. intenziv. Med. 2024;35(5):301-304 | DOI: 10.36290/aim.2024.060

Year 2024 in review - chronic pain therapyReview Article

Fricová J.

Klinika anesteziologie, resuscitace a intenzivní medicíny, Centrum pro léčbu bolesti 1. lékařské fakulty Univerzity Karlovy a Všeobecné fakultní nemocnice, Praha

The article presents a selection of interesting events such as World Pain Day, especially in the wake of the European Pain Day, which follows every third Wednesday in October. The Euro-Pean Union's influence on pain management is mentioned in a recent paper on painkillers, but the EU's interest in chronic pain is still rather marginal. IASP, the International Society for Pain Management, has declared 2024 the Global Year of Gender Differences in Pain. IASP has sought to shed light on this important topic during the global year and to bring about a change in attitude and understanding among doctors and patients. How gender differences may interact with the mechanisms that cause or maintain pain has been an area of growing interest in recent years. New findings have been published on cannabidiol, in particular, regulation will be needed not only for production but also for sales and advertising. Actually, in 2024, the first clinical practice guideline from the American Academy of Pediatrics (AAP) was released, bringing evidence-based approaches to safe opioid prescribing for acute pain in the paediatric population in outpatient settings. The primary goal is to help clinicians understand when opioids may be indicated for the treatment of acute pain in children and adolescents and how to minimize the risks of opioid use.

Keywords: World Pain Day, chronic pain, gender differences in pain, opioids, cannabidiol, acute pain in children, risks of pain management.

Received: December 9, 2024; Accepted: December 9, 2024; Published: December 19, 2024  Show citation